Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 216, Issue 9, Pages 1974-1985Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20181359
Keywords
-
Categories
Funding
- National Institutes of Health [1R01AI132447, AI127346, AI136990]
- Scleroderma Research Foundation
Ask authors/readers for more resources
Following the discovery of plasmacytoid dendritic cells (pDCs) and of their extraordinary ability to produce type I IFNs (IFN-I) in response to TLR7 and TLR9 stimulation, it is assumed that their main function is to participate in the antiviral response. There is increasing evidence suggesting that pDCs and/or IFN-I can also have a detrimental role in a number of inflammatory and autoimmune diseases, in the context of chronic viral infections and in cancers. Whether these cells should be targeted in patients and how much of their biology is connected to IFN-I production remains unclear and is discussed here.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available